In early data, new Pfizer COVID-19 boosters marshal antibodies against newer omicron variants
Flu Shots Protect Heart Failure Patients
Numerous clinical research studies have been published supporting the U.S. CDC's strong recommendation that most people measurably benefit from influenza vaccination.
A new peer-reviewed study published in The Lancet Global Health has identified another specific benefit.
An international team led by McMaster University researchers found that influenza vaccination significantly reduces pneumonia and cardiovascular complications in people with heart failure.
Percentage of U.S. Home Births Continued to Increase in 2021
12 percent increase seen from 2020 to 2021, with increases ranging from 10 to 21 percent for three largest race, Hispanic-origin groups
Seizures, Epilepsy Up in Six Months After COVID-19 Infection
Hazard ratio of seizures and epilepsy greater after COVID-19 versus influenza for those who were not hospitalized and those aged younger than 16 years
Seroprevalence to SARS-CoV-2 Has Increased Over Time
Global seroprevalence from infection or vaccination reached 59.2 percent by September 2021
FDA Oversight of Clinical Trials Described as ‘Grossly Inadequate’
Article describes inadequate oversight relating to development of COVID-19 vaccines and predating the pandemic
Multidimensional Factors Shaped Physician Stress During Pandemic
Physicians’ perceptions of occupational stress at individual level were shaped by stressors within and across four levels
Severe Outcomes From COVID-19 Up With Preexisting Neuropsych Conditions
Neuropsychiatric conditions and/or associated treatment linked to increased risk for severe outcomes from COVID-19, SARIs
Cardiac Risk Counseling Advised Before Monkeypox Vaccination
A recent non-peer-reviewed study based on Kaiser Permanente Northwest (KPNW) data intended to document any cardiac events associated with Bavarian Nordic's two-dose JYNNEOS® vaccine.
Since May 2022, about 600,000 people have received one or more vaccine doses in the U.S.
And New York City began offering people second doses of JYNNEOS in September 2022.
Immunologically, Hybrid Immunity Makes Sense
It is becoming clear that hybrid immunity, the immunity provided by a combination of infection and vaccination, offers better protection with diverse antibodies against subsequent COVID-19 infection than vaccination or infection alone, wrote a recent editorial published by The Lancet Infectious Diseases.
However, the real-world immunity picture is very complex.